Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Short communication · 2 Aug 2021 Conference abstract · 6 Nov 2017 Application of a health behaviour modification programme for benign prostatic hyperplasia patients in the non sung sub-district of Muang Udon Thani, Udon Thani Province, Thailand
Background: Benign Prostatic Hyperplasia is a chronic disease in older men whose flow of urine through the urethra is impeded by a non-malignant enlargement of the prostate. The problem ... this quasi-experimental…
Conference abstract · 25 Jul 2018 Trends in the development of novel approaches to cure benign prostatic hyperplasia: Hormones to 5α-reductase inhibitors
Benign prostatic hyperplasia (BPH) a common condition of aging men is characterized by nonmalignant enlargement of the prostate gland, and clinically manifested as lower urinary tract symptoms (LUTS). Past experience…
Conference abstract · 14 Aug 2018 Trends in the development of novel approaches to cure benign prostatic hyperplasia: Hormones to 5Ã?±-Reeducates inhibitors
Benign prostatic hyperplasia (BPH) a common condition of aging men is characterized by nonmalignant enlargement of the prostate gland, and clinically manifested as lower urinary tract symptoms (LUTS). Past experience…
Short communication · 2 Sep 2020 Management of Benign Prostatic Hyperplasia in Diabetic Patients: Endocrinologist Perspective
Statement of the Problem: Benign prostatic hyperplasia is a common problem in aging males. As studies suggest that at the age of 40, 5 to 10% of men have prostate ... efficacy in diabetic BPH patients. Conclusion &…
Conference abstract · 2 Oct 2017 Withania coagulans extract induces cell apoptosis and inhibits cox-2 expression in a rat model of benign prostatic hyperplasia
Phytotherapy is a popular treatment option in cases of benign prostatic hyperplasia (BPH), with many different herbal products being used for the treatment of this condition. Withania coagulans ... prostatic cell…
Conference abstract · 20 Jul 2015 Silodosin improves low urinary tract symptoms associated with benign prostatic hyperplasia
Introduction & Objective: Benign prostatic hyperplasia (BPH) is a globally prevalent histological condition with approximately 80% to 90% men aff ected in their 70s and 80s. Th e present study
Conference abstract · 2021 Benign prostate hyperplasia symptoms/quality of life are improved by a newly developed whole tomato-based food supplement: phase ii, prospective, randomized double blind, placebo-controlled study
Objective: Benign prostatic hyperplasia (BPH), highly frequent in elderly men, is associated with chronic inflammation, cardiovascular risk factors and with the presence of sexually transmitted diseases. The main…
Conference abstract · 13 Aug 2018 Benign prostatic hyperplasia thermo balancing therapy with cost effective Dr. Allens physiotherapeutic device reverses prostate enlargement
Allenâ??s therapeutic device (DATD) is a completely new treatment for benign prostatic hyperplasia (BPH). Nearly one in four men will suffer from BPH over their lifetime. BPH isnâ ... year empirical data show that men…
Conference abstract · 13 Aug 2018 Benign prostatic hyperplasia thermo balancing therapy with cost effective Dr. Allen’s physiotherapeutic device reverses prostate enlargement
Allen’s therapeutic device (DATD) is a completely new treatment for benign prostatic hyperplasia (BPH). Nearly one in four men will suffer from BPH over their lifetime ... year empirical data show that men around the…
Case report · 28 Feb 2023 Giant Benign Prostatic Hyperplasia - An Enigma of Largest Recorded Prostate in Malaysia
Conference abstract · 31 Aug 2020 The characteristics of benign prostatic hyperplasia (bph) in rsu haji medan 2015
Benign Prostatic Hyperplasia (BPH) is an enlarged prostate gland caused by progressive hyperplasia of glandular cells or stoma cells from prostate tissues. BPH is a common problem that increased
Review article · 1 Feb 2024 Apparent Differences in Prostate Zones: Susceptibility to Prostate Cancer and Benign Prostatic Hyperplasia
Men are inevitably plagued by prostate disease throughout their lives. However, the
Article · 30 Apr 2024 Relationship between age, prostate size, and Prostate Specific Antigen (PSA) role in patients with Benign Prostatic Hyperplasia (BPH)
Background: Benign Prostatic Hyperplasia (BPH) is a chronic, progressive disease that affects many older men. It has been demonstrated that the prevalence of disease increase with age. Prostate Specific Antigen
Case report 3500 ng/mL">Benign Prostatic Hyperplasia in 69 Years Old Man with Highest Serum PSA Level >3500 ng/mL
Objective: To describe a case of 69 years old man who had Benign Prostatic Hyperplasia (BPH) with highest serum Prostate Specific Antigen (PSA) (>3500 ng/mL). Materials and Methods: This
Conference abstract · 17 Oct 2016 Effects of thymoquinone treatment on testosterone-induced benign prostatic hyperplasia in Wistar rats
antiinflammatory, anti-oxidant and anticancer effects on in vitro and in vivo models. Benign prostatic hyperplasia (BPH) is the most common age-related disease in men. The present study ... folds. In TQ treated rats…
Conference abstract · 10 Aug 2015 Evaluation of the clinical indications, adverse drug reactions, and finasteride use in patients with benign prostatic hyperplasia in Poland
Benign prostatic hyperplasia (LUTS/BPH) is one of the most common urinary disorders in elderly men. Over the recent years, the number of surgical interventions performed in pharmacotherapy has significantly…
Conference abstract · 13 Sep 2016 Infectious cause of benign prostate hyperplasia
Background: Prostate cancer and benign prostatic hyperplasia (BPH) represents the most common urologic disease among the elderly males resulting in more than 2 million visits per year. BPH affects about ... this study…
Conference abstract · 27 Oct 2016 Development and evaluation of lipid-polymer hybrid systems for the treatment of benign prostate hyperplasia
Benign Prostate Hyperplasia (BPH) is a progressive-proliferative disorder commonly observed in males over 50 years of age and the incidence is on the rise due to aging population. Common ... could focus on using new…
Conference abstract · 24 Oct 2016 Potential use of reciprocal levels of serum and urinary peptides for discriminating prostate cancer from benign prostatic hyperplasia
potential serum and urine biomarkers that can discriminate prostate cancer (PCa) from benign prostatic hyperplasia (BPH) using gel and lectin-based proteomic approaches. Together, the investigations
Review article · 2016 Herbal Management of Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH) is an age dependent condition that affects old men. The condition is associated with symptoms like frequency in urination, hesistancy, nocturia, weak urine stream and sexual
Research article · 3 May 2019 Development of reservoir type transdermal drug delivery system of alfuzosin hydrochloride for the treatment of benign prostate hyperplasia
Benign prostate hyperplasia (BPH) is a condition occurring with geriatric group of patients. But the absolute bioavailability of alfuzosin is about 49% under fed conditions; the corresponding value under fasting
Conference abstract · 22 Jun 2015 Establishment of prostate cancer and benign prostatic hyperplasia PDX (patient-derived xenograft) in super-SCID mice
These PC-PDXs will be very useful for basic researches and drug development. Benign prostatic hyperplasia (BPH) is the most common disease, decreasing QOL in older men. We succeeded
Conference abstract · 2 Oct 2017 Plant extracts alleviate urinary dysfunction in patients with benign prostatic hyperplasia and overactive bladder
Lower Urinary Tract Symptoms (LUTS) caused by Benign Prostatic Hyperplasia (BPH), overactive bladder (OAB) and Interstitial Cystitis (IC) are very common urinary disorders in geriatric population. In addition…
Conference abstract · 16 Jul 2018 Use of free to total prostate-specific antigen ratio to improve differentiation of prostate cancer from benign prostate hyperplasia in Sudanese patients
TPSA ratio to improve differentiation of prostate cancer from benign prostatic hyperplasia in Sudanese patients in Khartoum state. Materials & Methodology: A prospective, analytical, hospital based study case control…

